Humanwell Healthcare (Group) Co.,Ltd.

Humanwell Healthcare (Group) Co.,Ltd.

Share · CNE000000QW6 (XSHG)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Humanwell Healthcare (Group) Co.,Ltd.
No Price
Closing Price XSHG 29.04.2026: 19,21 CNY
29.04.2026 07:00
Current Prices from Humanwell Healthcare (Group) Co.,Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHG: SSE
SSE
600079.SS
CNY
29.04.2026 07:00
19,21 CNY
0,61 CNY
+3,28 %
Share Float & Liquidity
Free Float 72,84 %
Shares Float 1,19 B
Shares Outstanding 1,63 B
Invested Funds

The following funds have invested in Humanwell Healthcare (Group) Co.,Ltd.:

Fund
iShares MSCI China UCITS ETF USD (Dist)
Vol. in million
0,31
Percentage (%)
0,0094 %
Company Profile for Humanwell Healthcare (Group) Co.,Ltd. Share
Humanwell Healthcare (Group) Co.,Ltd. provides healthcare solutions in the Asia Pacific, North America, Africa, and internationally. The company offers anesthetic/analgesic products; women's health products for unplanned pregnancy, emergency contraception, and birth control; consumer healthcare products for women; and CNS drugs for bronchitis, migraine, dysmenorrhea, neuralgia, epilepsy, acute and chronic cerebrovascular diseases, and brain injury and peripheral vascular diseases. It also provides herbal medicines for cold and flu, rheumatoid arthritis, skin care, hepatitis, urinary tract infection, and hypomnesis; anti-infection drugs; OTC medicines for digestive disorders, cold and flu, anti-inflammation, anti-infection, and nutritional supplements; and other products targeting cardiovascular, gastrointestinal, and reproductive diseases. The company was formerly known as Wuhan Humanwell Healthcare (Group) Co., Ltd. and changed its name to Humanwell Healthcare (Group) Co.,Ltd. in March 2013. Humanwell Healthcare (Group) Co.,Ltd. was founded in 1993 and is based in Wuhan, China.

Company Data

Name Humanwell Healthcare (Group) Co.,Ltd.
Company Humanwell Healthcare (Group) Co.,Ltd.
Website https://www.humanwell.com.cn
Primary Exchange XSHG SSE
ISIN CNE000000QW6
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Xiafei Deng
Market Capitalization 30 Mrd.
Country China
Currency CNY
Employees 17,7 T
Address No.666 Gaoxin Road, 430075 Wuhan
IPO Date 1997-06-06
Dividends from 'Humanwell Healthcare (Group) Co.,Ltd.'
Ex-Date Dividend per Share
19.08.2025 0,32 CNY
11.10.2024 0,15 CNY
24.06.2024 0,46 CNY
16.06.2023 0,16 CNY
25.07.2022 0,15 CNY
27.07.2021 0,10 CNY
28.07.2020 0,05 CNY
05.07.2018 0,16 CNY
16.06.2017 0,11 CNY
22.07.2016 0,10 CNY

Stock Splits

Date Split
22.07.2015 2:1
13.06.2007 3:2
17.08.2005 6:5
30.05.2003 7:5
31.08.2000 19:10

Ticker Symbols

Name Symbol
SSE 600079.SS
More Shares
Investors who hold Humanwell Healthcare (Group) Co.,Ltd. also have the following shares in their portfolio:
Kaimei Electronic Corp.
Kaimei Electronic Corp. Share
ZyVersa Therapeutics, Inc. - Common Stock
ZyVersa Therapeutics, Inc. - Common Stock Share